These studies reveal a novel function and underlying mechanisms of CaM in regulating TRA-8-induced apoptosis, and support the use of the readily available CaM antagonists to enhance therapeutic efficacy of TRAIL-resistant pancreatic cancer to TRAIL-agonist therapy. Here, TNFSF10 is linked to pancreatic neoplasm.